Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Diabetologia. 2018 Dec 19;62(4):655–664. doi: 10.1007/s00125-018-4786-9

Fig. 3.

Fig. 3

Relationship between the baseline C-peptide and the C-peptide at follow-up. The baseline C-peptide and change in C-peptide are shown for the three groups (loge[(AUC/240)+1], in nmol/l). There was a significant relationship between the baseline C-peptide and the change for the control participants (Spearman r=−0.704, p=0.005) and drug-treated non-responders (r=−0.836, p=0.002) but not the drug-treated responders (r=−0.297, p=0.41)